企业投融资与合作方面Orchestra BioMed 获战略投资:Ligand 和美敦力共注入 7000 万美元。其中,Ligand 投资 3500 万美元换取其 AVIM 疗法和 Virtue SAB 未来销售额分级特许权使用费,另在股权私募投资 500 万美元;美敦力在股权私募投资 1000 万美元,另通过可转换为预付收入份额的担保次级本票投资 2000 万美元。双方同时扩大战略合作,推进 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.